DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
van der Heijde D, Tanaka Y, Fleischmann R. et al.
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study.
Arthritis Rheum 2013;
65: 559-570
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.